EZH2 and breast carcinoma: In summary, these results indicate that histone modification participates in the regulation of PDK1 by inhibiting miR-148a, and the existence of the HDAC2/EZH2/miR-148a/PDK1 regulatory axis may be important in breast cancer development and therapeutic resistance (Figure 8F).